Widespread Alternative Splicing Changes in Metastatic Breast Cancer Cells

Aberrant alternative splicing (AS) is a hallmark of cancer and a potential target for novel anti-cancer therapeutics. Breast cancer-associated AS events are known to be linked to disease progression, metastasis, and survival of breast cancer patients. To identify altered AS programs occurring in met...

Full description

Bibliographic Details

Published in:	Cells
Main Authors:	Jagyeong Oh, Davide Pradella, Changwei Shao, Hairi Li, Namjeong Choi, Jiyeon Ha, Sonia Ruggiero, Xiang-Dong Fu, Xuexiu Zheng, Claudia Ghigna, Haihong Shen
Format:	Article
Language:	English
Published:	MDPI AG 2021-04-01
Subjects:	alternative splicing breast cancer exon skipping cancer metastasis <i>DCUN1D5</i>
Online Access:	https://www.mdpi.com/2073-4409/10/4/858